Search Results | Cancer Research | American Association for Cancer Research

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Abstract 2716: P-selectin axis plays a key role in microglia immunophenotype and glioblastoma progression

Eilam Yeini, Paula Ofek, Sabina Pozzi, Nitzan Albeck, Dikla Ben-Shushan, Galia Tiram, Sapir Golan, Ron Kleiner, Ron Sheinin, Shlomit Reich-Zeliger, Rachel Grossman, Zvi Ram, Henry Brem, Thomas Hyde, Prerna Magod, Dinorah Friedmann-Morvinski, Asaf Madi, Ronit Satchi-Fainaro

Cancer Res (2021) 81 (13_Supplement): 2716.

DOI: https://doi.org/10.1158/1538-7445.AM2021-2716

Published: 01 July 2021

View article

Journal Articles

Abstract CT219: Efficacy of TTFields in elderly patients with newly diagnosed glioblastoma (GBM): Sub-group analysis of the EF-14 trial

Zvi Ram, Jay-Jiguang Zhu

Cancer Res (2020) 80 (16_Supplement): CT219.

DOI: https://doi.org/10.1158/1538-7445.AM2020-CT219

Published: 15 August 2020

View article

Journal Articles

Abstract CT211: EF-19 - A post-approval registry study of TTFields for the treatment of recurrent glioblastoma (GBM)

Jay-Jiguang Zhu, Robert T. O'Donnell, Zvi Ram

Cancer Res (2020) 80 (16_Supplement): CT211.

DOI: https://doi.org/10.1158/1538-7445.AM2020-CT211

Published: 15 August 2020

View article

Journal Articles

Abstract CT206: Concurrent Tumor Treating Fields (TTFields) and radiation therapy for newly diagnosed glioblastoma: A safety and feasibility study

Felix Bokstein, Deborah Blumenthal, Dror Limon, Carmit Ben Harosh, Zvi Ram, Rachel Grossman

Cancer Res (2020) 80 (16_Supplement): CT206.

DOI: https://doi.org/10.1158/1538-7445.AM2020-CT206

Published: 15 August 2020

View article

Journal Articles

Abstract CT203: Randomized Phase II trial of Tumor Treating Fields plus radiation therapy plus temozolamide compared to radiation therapy plus temozolomide in patients with newly diagnosed glioblastoma

Rachel Grossman, Dror Limon, Felix Bokstein, Carmit Ben Harosh, Zvi Ram

Cancer Res (2019) 79 (13_Supplement): CT203.

DOI: https://doi.org/10.1158/1538-7445.AM2019-CT203

Published: 01 July 2019

View article

Journal Articles

Abstract CT008: Tumor Treating Fields combined with radiotherapy and temzolomide for newly diagnosed glioblastoma: Final results from a pilot study

Rachel Grossman, Dror Limon, Felix Bokstein, Zvi Ram

Cancer Res (2019) 79 (13_Supplement): CT008.

DOI: https://doi.org/10.1158/1538-7445.AM2019-CT008

Published: 01 July 2019

View article

Journal Articles

Abstract 3954: Evaluating the compatibility of tumor treating electric fields with key anti-tumoral immune functions

Gil Diamant, Hadar Simchony, Tamar Shiloach, Anat Globerson-levin, Lital Gasri Plotnitsky, Zelig Eshhar, Niv Pencovich, Rachel Grossman, Zvi Ram, Ilan Volovitz

Cancer Res (2019) 79 (13_Supplement): 3954.

DOI: https://doi.org/10.1158/1538-7445.AM2019-3954

Published: 01 July 2019

View article

Journal Articles

Abstract 2272: Identification of predictive biomarkers for immunotherapy of brain and solid tumors by studying inter-cellular immune networks

Ilan Volovitz, Gil Diamant, Marina Roitman, Nati Shapira, Roni Hagai, Barak Bensimhon, Merav Lustgarten, Rachel Grossman, Zvi Ram

Cancer Res (2018) 78 (13_Supplement): 2272.

DOI: https://doi.org/10.1158/1538-7445.AM2018-2272

Published: 01 July 2018

View article

Journal Articles

Abstract CT086: Safety of TTFields and radiotherapy (RT) for newly diagnosed glioblastoma: Interim safety results from a pilot study

Rachel Grossman, Zvi Ram

Cancer Res (2018) 78 (13_Supplement): CT086.

DOI: https://doi.org/10.1158/1538-7445.AM2018-CT086

Published: 01 July 2018

View article

Journal Articles

Abstract 621: Evaluating the compatibility of tumor treating electric fields with key anti-tumoral T cell functions

Gil Diamant, Hadar Simchony, Tamar Shiloach, Anat Globerson-levin, Zelig Eshhar, Rachel Grossman, Zvi Ram, Ilan Volovitz

Cancer Res (2018) 78 (13_Supplement): 621.

DOI: https://doi.org/10.1158/1538-7445.AM2018-621

Published: 01 July 2018

View article

Journal Articles

Abstract CT007: Tumor treating fields added to standard chemotherapy in newly diagnosed glioblastoma (GBM): Final results of a randomized, multi-center, phase III trial

Cancer Res (2017) 77 (13_Supplement): CT007.

DOI: https://doi.org/10.1158/1538-7445.AM2017-CT007

Published: 01 July 2017

View article

Journal Articles

Abstract 617: Evaluating the in-vitro effects of tumor treating fields on T cell responses

Gil Diamant, Ilan Volovitz, Zvi Ram

Cancer Res (2017) 77 (13_Supplement): 617.

DOI: https://doi.org/10.1158/1538-7445.AM2017-617

Published: 01 July 2017

View article

Journal Articles

Convection-Enhanced Drug Delivery: Increased Efficacy and Magnetic Resonance Image Monitoring

Yael Mardor, Ofer Rahav, Yacov Zauberman, Zvi Lidar, Aharon Ocherashvilli, Dianne Daniels, Yiftach Roth, Stephan E. Maier, Arie Orenstein, Zvi Ram

Cancer Res (2005) 65 (15): 6858–6863.

DOI: https://doi.org/10.1158/0008-5472.CAN-05-0161

Published: 01 August 2005

View article

Journal Articles

Ammonium Trichloro(dioxoethylene- o,o ′)tellurate (AS101) Sensitizes Tumors to Chemotherapy by Inhibiting the Tumor Interleukin 10 Autocrine Loop

Benjamin Sredni, Merav Weil, Gennadi Khomenok, Ilana Lebenthal, Seagal Teitz, Yael Mardor, Zvi Ram, Arie Orenstein, Amir Kershenovich, Shalom Michowiz, Yan I. Cohen, Zvi H. Rappaport, Ilya Freidkin, Michael Albeck, Dan L. Longo, Yona Kalechman

Cancer Res (2004) 64 (5): 1843–1852.

DOI: https://doi.org/10.1158/0008-5472.CAN-03-3179

Published: 02 March 2004

View article

Journal Articles

Monitoring Response to Convection-enhanced Taxol Delivery in Brain Tumor Patients Using Diffusion-weighted Magnetic Resonance Imaging

Yael Mardor, Yiftach Roth, Zvi Lidar, Tali Jonas, Raphael Pfeffer, Stephan E. Maier, Meir Faibel, Dvora Nass, Moshe Hadani, Arie Orenstein, Jack S. Cohen, Zvi Ram

Cancer Res (2001) 61 (13): 4971–4973.

Published: 01 July 2001

View article

Journal Articles

In Situ Cyclopentenyl Cytosine Infusion for the Treatment of Experimental Brain Tumors

John J. Viola, Riad Agbaria, Stuart Walbridge, Eric M. Oshiro, David G. Johns, James A. Kelley, Edward H. Oldfield, Zvi Ram

Cancer Res (1995) 55 (6): 1306–1309.

Published: 01 March 1995

View article

Journal Articles

Growth Inhibition, Tumor Maturation, and Extended Survival in Experimental Brain Tumors in Rats Treated with Phenylacetate

Zvi Ram, Dvorit Samid, Stuart Walbridge, Eric M. Oshiro, John J. Viola, Jung-Hwa Tao-Cheng, Sonsoles Shack, Alain Thibault, Charles E. Myers, Edward H. Oldfield

Cancer Res (1994) 54 (11): 2923–2927.

Published: 01 June 1994

View article

Journal Articles

Intrathecal Gene Therapy for Malignant Leptomeningeal Neoplasia

Zvi Ram, Stuart Walbridge, Eric M. Oshiro, John J. Viola, Yawen Chiang, Stephan N. Mueller, R. Michael Blaese, Edward H. Oldfield

Cancer Res (1994) 54 (8): 2141–2145.

Published: 01 April 1994

View article

Journal Articles

Selective Activity of Phenylacetate against Malignant Gliomas: Resemblance to Fetal Brain Damage in Phenylketonuria

Dvorit Samid, Zvi Ram, W. Robert Hudgins, Sonsoles Shack, Lei Liu, Stuart Walbridge, Edward H. Oldfield, Charles E. Myers

Cancer Res (1994) 54 (4): 891–895.

Published: 01 February 1994

View article

Journal Articles

In Situ Retroviral-mediated Gene Transfer for the Treatment of Brain Tumors in Rats

Zvi Ram, Kenneth W. Culver, Stuart Walbridge, R. Michael Blaese, Edward H. Oldfield

Cancer Res (1993) 53 (1): 83–88.

Published: 01 January 1993

View article

NARROW

Abstract 2716: P-selectin axis plays a key role in microglia immunophenotype and glioblastoma progression

Abstract CT219: Efficacy of TTFields in elderly patients with newly diagnosed glioblastoma (GBM): Sub-group analysis of the EF-14 trial

Abstract CT211: EF-19 - A post-approval registry study of TTFields for the treatment of recurrent glioblastoma (GBM)

Abstract CT206: Concurrent Tumor Treating Fields (TTFields) and radiation therapy for newly diagnosed glioblastoma: A safety and feasibility study

Abstract CT203: Randomized Phase II trial of Tumor Treating Fields plus radiation therapy plus temozolamide compared to radiation therapy plus temozolomide in patients with newly diagnosed glioblastoma

Abstract CT008: Tumor Treating Fields combined with radiotherapy and temzolomide for newly diagnosed glioblastoma: Final results from a pilot study

Abstract 3954: Evaluating the compatibility of tumor treating electric fields with key anti-tumoral immune functions

Abstract 2272: Identification of predictive biomarkers for immunotherapy of brain and solid tumors by studying inter-cellular immune networks

Abstract CT086: Safety of TTFields and radiotherapy (RT) for newly diagnosed glioblastoma: Interim safety results from a pilot study

Abstract 621: Evaluating the compatibility of tumor treating electric fields with key anti-tumoral T cell functions

Abstract CT007: Tumor treating fields added to standard chemotherapy in newly diagnosed glioblastoma (GBM): Final results of a randomized, multi-center, phase III trial

Abstract 617: Evaluating the in-vitro effects of tumor treating fields on T cell responses

Convection-Enhanced Drug Delivery: Increased Efficacy and Magnetic Resonance Image Monitoring

Ammonium Trichloro(dioxoethylene- o,o ′)tellurate (AS101) Sensitizes Tumors to Chemotherapy by Inhibiting the Tumor Interleukin 10 Autocrine Loop

Monitoring Response to Convection-enhanced Taxol Delivery in Brain Tumor Patients Using Diffusion-weighted Magnetic Resonance Imaging

In Situ Cyclopentenyl Cytosine Infusion for the Treatment of Experimental Brain Tumors

Growth Inhibition, Tumor Maturation, and Extended Survival in Experimental Brain Tumors in Rats Treated with Phenylacetate

Intrathecal Gene Therapy for Malignant Leptomeningeal Neoplasia

Selective Activity of Phenylacetate against Malignant Gliomas: Resemblance to Fetal Brain Damage in Phenylketonuria

In Situ Retroviral-mediated Gene Transfer for the Treatment of Brain Tumors in Rats

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only